REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 2 filers reported holding REVOLUTION MEDICINES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,727 | +627.0% | 20,691 | +602.6% | 0.02% | +500.0% |
| Q2 2023 | $78,779 | +106358.1% | 2,945 | -13.8% | 0.00% | +50.0% |
| Q1 2023 | $74 | +60.9% | 3,418 | +76.5% | 0.00% | 0.0% |
| Q4 2022 | $46 | -100.0% | 1,937 | -67.5% | 0.00% | 0.0% |
| Q3 2022 | $117,000 | -4.9% | 5,951 | -5.8% | 0.00% | -33.3% |
| Q2 2022 | $123,000 | -35.3% | 6,319 | -15.1% | 0.00% | +50.0% |
| Q1 2022 | $190,000 | +1.1% | 7,439 | -0.6% | 0.00% | -33.3% |
| Q4 2021 | $188,000 | +12.6% | 7,483 | +23.4% | 0.00% | -25.0% |
| Q3 2021 | $167,000 | +24.6% | 6,066 | +43.8% | 0.00% | +33.3% |
| Q2 2021 | $134,000 | +42.6% | 4,219 | +106.5% | 0.00% | +50.0% |
| Q1 2021 | $94,000 | -38.6% | 2,043 | -47.1% | 0.00% | -60.0% |
| Q4 2020 | $153,000 | -57.1% | 3,863 | -62.3% | 0.01% | +25.0% |
| Q3 2020 | $357,000 | +301.1% | 10,247 | +262.5% | 0.00% | 0.0% |
| Q2 2020 | $89,000 | – | 2,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |